Finance

Lists
Why is MIRA down २०.८४%?
Dive Deeper
MIRA:NASDAQ
Mira Pharmaceuticals Inc
US$ ०.२९
-२०.८४%
(-०.०७७) 1D
US$ ०.३०
+२.०६% (+०.००६०)
After hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRA...
Open
US$ ०.३९
High
US$ ०.३९
Low
US$ ०.२६
Mkt. cap
१.२२ करोड
Avg. vol.
१.५१ लाख
Volume
५.७० लाख
52-wk high
US$ १.६९
52-wk low
US$ ०.२६
EPS
-US$ १.३८
Beta
१.६४
Shares outstanding
४.२० करोड
No. of employees
३
Open
US$ ०.३९
High
US$ ०.३९
Low
US$ ०.२६
Mkt. cap
१.२२ करोड
Avg. vol.
१.५१ लाख
Volume
५.७० लाख
52-wk high
US$ १.६९
52-wk low
US$ ०.२६
EPS
-US$ १.३८
Beta
१.६४
Shares outstanding
४.२० करोड
No. of employees
३
News stories
From web sources and news partners
About Mira Pharmaceuticals Inc
CEO-
Employees३
Founded२०२०
Headquartersमायामी, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to MIRA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MIRA in the last 3 months
Highest
Current US$ ०.२९
US$ ३.५० (+१,१०२.७५%)
Average
US$ ३.५० (+१,१०२.७५%)
Lowest
US$ ३.५० (+१,१०२.७५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ३.५०
+१,१०२.७%
11/18/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ ८.००
+२,६४९.१%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४.९७ लाख
५.२५ लाख
७.०६ लाख
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५३.२८ लाख
५.७९ लाख
४.५० लाख
-
Operating expense
५८.२५ लाख
११.०३ लाख
११.५६ लाख
-
Total operating expenses
५८.२५ लाख
११.०३ लाख
११.५६ लाख
-
Operating income
-५८.२५ लाख
-११.०३ लाख
-११.५६ लाख
-
Other non operating income
-३९६.००
-
-
-
EBT including unusual items
-५९.८३ लाख
-११.५० लाख
-१२.०९ लाख
-
EBT excluding unusual items
-५७.७२ लाख
-११.५० लाख
-१२.०९ लाख
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-५९.८३ लाख
-११.५० लाख
-१२.०९ लाख
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
५३.१७ हजार
४४.९१ हजार
३५.१३ हजार
-
Interest expense
-
-
-
-
Net interest expenses
५३.१७ हजार
४४.९१ हजार
३५.१३ हजार
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू